Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.53, p.347-351, 2006 |
||
Title: Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma | ||
Author: O., CELEN ; E., YILDIRIM ; N., OZEN ; C., SONMEZ ; | ||
Abstract: The aim of this study was to determine whether relative changes in total serum sialic acid (TSA) levels are associated with
response to neoadjuvant chemotherapy in locally advanced breast carcinoma (LABC) patients. Forty-seven patients with
stage III-B breast carcinoma and 20 healthy subjects (controls) were included to the study. TSA levels were determined in
serum from patients at baseline and after completion of preoperative chemotherapy. Pathological responses to chemotherapy
were determined on specimens of modified radical mastectomy underwent in responders. Association between the relative
changes in serum TSA levels and the pathological response to chemotherapy was investigated. The baseline mean serum
TSA level of LABC patients was 88.6±0.6 mg/dl and 66.9±0.7 mg/dl for the control group (p<0.0001). After 3 cycles
chemotherapy, the serum levels of TSA were markedly decreased with pathological partial response (pPR) (73.8±1.0 mg/dl)
and complete response (pCR) (68.1±1.9 mg/dl) compared to baseline values (p<0.05). In 8 non-responders, mean TSA value
was 88.9±1.1 mg/dl (p=0.9 for pretreatment vs posttreatment TSA levels). Of 39 responders, 6 had pathological complete
response (pCR) and remaining had pathological partial response (pPR). TSA levels derived from patients with pCR and
from those with pPR were 68.1±1.9 mg/dl and 73.8±1.0 mg/dl, respectively (p=0.03). While TSA levels from pCR were not
different from those of controls (p=0.4), there was a significant difference between TSA levels from pPR and from controls
(p<0.0001). A significant correlation was demonstrated between the relative changes in TSA levels and pathological response
(p<0.0001, coefficient of correlation [rs]=0.81). The ROC analysis showed that the discriminating ability was satisfactory
and relative decrease by more than 21% in TSA levels indicated a pCR with the sensitivity by 83%, specificity by
76%. In conclusion, there is a significant correlation between the relative changes in TSA levels by chemotherapy and clinical/
pathological response to neoadjuvant chemotherapy in LABC patients.
|
||
Keywords: sialic acid, response, neoadjuvant chemotherapy, breast carcinoma | ||
Year: 2006, Volume: 53, Issue: | Page From: 347, Page To: 351 | |
|
download file |
|